Market Cap 101.88B
Revenue (ttm) 48.30B
Net Income (ttm) -8.95B
EPS (ttm) N/A
PE Ratio 6.39
Forward PE 6.80
Profit Margin -18.53%
Debt to Equity Ratio 2.85
Volume 14,915,300
Avg Vol 14,814,088
Day's Range N/A - N/A
Shares Out 2.04B
Stochastic %K 3%
Beta 0.39
Analysts Sell
Price Target $56.48

Latest News on BMY

Top 3 Health Care Stocks That May Rocket Higher In April

Apr 28, 2025, 7:16 AM EDT - 13 days ago

Top 3 Health Care Stocks That May Rocket Higher In April

UNH XFOR


Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap

Apr 28, 2025, 7:15 AM EDT - 13 days ago

Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap

VZ


5 Positives From Bristol-Myers Squibb's Q1 2025 Results

Apr 25, 2025, 10:27 AM EDT - 16 days ago

5 Positives From Bristol-Myers Squibb's Q1 2025 Results


Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance

Apr 25, 2025, 9:00 AM EDT - 16 days ago

Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance


Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results

Apr 24, 2025, 1:11 PM EDT - 17 days ago

Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results


Bristol-Myers Squibb Is A Good Pick

Apr 24, 2025, 11:56 AM EDT - 17 days ago

Bristol-Myers Squibb Is A Good Pick


Healthcare Stocks Aren't a Shelter From the Tariff Storm

Apr 9, 2025, 12:04 PM EDT - 4 weeks ago

Healthcare Stocks Aren't a Shelter From the Tariff Storm

LLY PFE XLV